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ABSTRACT The question of whether the skeleton meta-
bolizes 25-hydroxycholecalciferol [25(OH)D3] to more-polar
products was studied. Calvarial cells were dispersed from 18day
old chicken embryos by using collagenase and then grown in
culture in serum-free medium. Confluent cell cultures were in-
cubated with 7 nM 25(OH3H3 for 2 hr, and the vitamin D
metabolites were then extracted. At least four polar metabolites
were produced. Based on separation by Sephadex LH-20 chro-
matography followed by hiNFressure liquid chromatography,
two of these metabolites were identified as 1,25-dihydroxy-
cholecalciferol [1,25(OH)2D3] and 24,25-dihydroxycholecalcif-
erol [24,25(OH)2D3. These metabolites were also produced by
cultured kidney cells but not by liver, heart muscle, or skin cells
isolated from the same embryos. The specific activities of the
calvarial 1- and 24-hydroxylases were similar in magnitude to
those in isolated kidney cells. The specific activity of the cal-
varial 25(OH)D3:1-hydroxylase was inhibited by an 8-hr pre-
incubation with 1,25(OH)2D3, whereas the 24-hydroxylase was
enhanced. It is concluded that (i) vitamin D metabolism by
isolated cells is organ-specific, (ii) calvarial cells produce active
metabolites of vitamin D in significant amounts, (lii) vitamin
D metabolism by calvarial ce is reglated by 1,2Z(OHhD3,
and (iv) locally produced, active meta lites could act locally,
thereby adding a new dimension to the regulation of mineral
metabolism by vitamin D metabolites.
la,25-Dihydroxycholecalciferol [1,25(OH)2D3] is a potent
mineral homeostatic hormone. It acts on the skeleton to mobilize
bone mineral and on the intestine to enhance absorption of
calcium and phosphorus (1-3). In addition, it appears to act on
the kidney, in concert with parathyroid hormone (PTH), to
promote calcium reabsorption (4). It was formerly believed that
1,25(OH)2D3 is synthesized exclusively in the kidney but recent
evidence suggests that it may be synthesized in placenta as well
(5-7). In this paper, we report that cells isolated from calvaria
of chicken embryos and grown in culture metabolize 25-hy-
droxycholecalciferol [25(OH)D3] to several more-polar me-
tabolites, including 1,25(OH)2D3. These findings suggest that
the tissue distribution of 1,25(OH)2D3 production may be wider
than previously thought and that locally produced as well as
systemically derived hormone may be important in mediating
vitamin D action in target organs such as the skeleton.
MATERIALS AND METHODS
Isolation of Cells. Cells were isolated from calvaria of 15-
to 16-day chicken embryos (Gallus gallus, Fors Farms
Hatchery, Puyallup, WA) by a modification of the method
developed for fetal rat calvaria (8). Briefly, the frontal and
parietal bones and intervening suture line area were aseptically
dissected, rinsed, and incubated for up to 120 min in Tris-
HCI/NaCl, pH 7.4 (four calvaria per ml) containing collagenase
(2 mg/ml; Worthington, type II). The cells were recovered as
described (8), washed twice in enzyme-free Hanks' buffer (pH
7.4), and diluted in BGJb medium (Fitton-Jackson modification,
GIBCO) (9) containing 100 units of penicillin and 100 ,g
streptomycin per ml. Cell number was determined by counting
with a hemacytometer.
Kidney, skin, liver, and heart tissue were aseptically dissected
from 15- to 16-day chicken embryos and minced into pieces no
larger than 1 mm3, and the cells were isolated as described
(10).
Culture Conditions. Calvarial cells were suspended in
serum-free BGJb medium, plated at a density of 1200-1500 cells
per mm2 of culture dish, and incubated at 370C in 5% CO2/
95% air. The medium (2.5 ml/60mm dish) was changed after
48 hr and again before assaying vitamin D metabolism in
confluent cultures (approximately 72-96 hr).
Kidney, liver, skin, and heart cells were grown in the same
manner as the calvarial cells. Kidney, liver, and skin cells be-
came confluent within 4 days. Heart cells did not reach con-
fluency; however, they remained viable and retained differ-
entiated function (beating) for 4 days in culture.
Metabolism of 25-Hydroxy[26(27)-methyl-3H]cholecal-
ciferol [25(0HX3HID3]. 25(0H)[3H]D3 (7 nM; 9 Ci/mmol; 1
Ci = 3.7 X 101" becquerels; Amersham) was incubated with the
cultured cells for 2 hr (with ethanol at a final concentration of
0.1% as the carrier) (10). In one experiment, isolated calvarial
cells were preincubated with 10 nM of 1,25(OH)2D3 for 8 hr
before addition of 25(OH)[3H]D3. Dichloromethane extracts
of the cultured cells and medium were evaporated to dryness
under a gentle stream of N2, resuspended in a small volume of
hexane/chloroform/methanol (9:1:1), and chromatographed
on Sephadex LH-20 columns (Pharmarcia) (1 X 56 cm; 15 g of
LH-20) previously equilibrated with the same solvent system.
Three-milliliter fractions were collected for determination of
the radioactivity (10); 80-95% of the radioactivity added to
calvarial cells was recovered after separation of vitamin D
metabolites by Sephadex LH-20 column chromatography.
Polar metabolites of 25(OH)[3H]D3 were identified by
comparing their elution volumes with those of authentic stan-
dards on Sephadex LH-20 columns, by periodate (aqueous)
cleavage of the peak fractions (11), and by high-pressure liquid
chromatography (HPLC) of the peak fractions.
HPLC of Polar Metabolites. Fractions that migrated
in the 1,25(OH)2D3 and 24,25-dihydroxycholecalciferol
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[24,25(OH)2D3] regions after Sephadex LH-20 column chro-
matography were pooled, dried under N2, and redissolved in
the appropriate solvent. These pooled fractions were cochro-
matographed with synthetic 1,25(OH)2D3 and 24,25(OH)2D3,
respectively (donated by M. Uskokovic, Hoffmann-La Roche,
Nutley, NJ), on an HPLC system (Laboratory Data Control,
Riviera Beach, FL) using a Zorbax-Sil (4.6 mm X 25 cm) col-
umn and the following solvent systems: (i) hexane/isopropanol
(90:10) at a flow rate of 1 ml/min and (U) hexane/isopropanol
(87:13) at a flow rate of 1 mI/min. 1,25(OH)2[3H]D3 was re-
cycled on the latter system by rechromatographing the
1,25(OH)2D3 region four times. An aliquot of the coeluting
fraction was then subjected to HPLC on a reverse-phase column
(0.8 X 10 cm cartridge, Radial-Pak A, Waters Associates) with
a mobile phase of methanol/water (gradient of 75:25 to 95:5
over 30 min) at a flow rate of 1 ml/min.
RESULTS
Characterization and Isolation of Calvarial Cells. A lon-
gitudinal section through a calvarium from a 16-day embryo
showed that osteoblasts (plump cells having negative Golgi lying
immediately adjacent to bone) lined most of the endosteal and
periosteal surfaces of the calvarium (Fig. 1). Osteocytes were
numerous in the intact calvarium. In contrast, osteoclasts
[identified by staining for acid phosphatase (12)] were relatively
rare (1% of the osteoblast number). In addition, the calvaria
contained bone precursor cells as well as connective tissue fi-
broblasts and capillary endothelial cells. There was no bone
marrow. The effect of collagenase treatment on calvaria was
to release all of the cells except the deepest osteocytes (Fig. 1B).
However, it is not clear whether all of the cell types that were
released attached to tissue culture dishes or remained viable in
culture.
Metabolites of 25(OX3HjD3 Produced by Isolated Cal-
varial Cells. Vitamin D metabolism was assayed in calvarial
cells after the cultures reached confluence. Calvarial cells
metabolized 25(OH)[3H]D3 to more-polar compounds; these
metabolites were produced without failure in more than 70
separate preparations of calvarial cells but were not produced
in medium that did not contain cells. Two of the metabolites
were identified on the basis of elution volume on Sephadex
LH-20 as 1,25(OH)2D3 and 24,25(OH)2D3 (Fig. 2). The
1,25(OH)2D3 and 24,25(OH)2D3 regions appeared to be ho-
mogeneous with respect to reaction with periodate: on periodate
treatment, 93 + 1% (mean + SD; n = 3) of the radioactivity in
the 24,25(OH)2D3 region and 0 I 1% of the radioactivity in the
1,25(OH)2D3 region was lost. Furthermore, the material in the
24,25(OH)2D3 and 1,25(OH)2D3 regions comigrated exactly
with crystalline standards when cochromatographed on several
HPLC systems (Figs. 3 and 4, respectively). The structures of
two polar metabolites, IV and V, have not yet been deter-
mined.
We do not know what cells from calvaria metabolized
25(OH)D3 or whether the 25(OH)D3:1-hydroxylase and
25(OH)D3:24-hydroxylase are located in the same cells. How-
ever, it is likely that these enzymes were located in cells unique
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FIG. 1. Transverse sections through calvaria from 16-day embryos. (A) Sections (5 AM) were stained with methyl green and thionine. Os-
teoblasts cover all surfaces of the bone. (B) Digested with collagenase for 120 min. With the exception of the deepest osteocytes, all of the cells
in the calvarium have been released. The length of the bar equals 100,gm.
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FIG. 2. Polar metabolites of 25(OH)[3HID3 produced byprimary
cultures of chicken embryo calvarial cells. Cells (8-10 X 16) were
incubated for 2 hr with 25(OH)[3HID3 (7 nM) and extracted with
dichloromethane. The extracted vitamin D metabolites were sepa-
rated on Sepha~ex LH-20 (1 X 56 cm; 16 g) columns by elution with
hexane/chloroform/methanol (9:1:1). Roman numerals refer to un-
identified metabolites. -, Representative metabolic profile from
control cultures; - - -, differences that occur after an 8-hr preincuba-
tion with 10 nM 1,25(OH)2D3 I
to bone (differentiated bone cells or their precursors)
rather than in endothelial cells or fibroblasts, because the latter,
also common to liver, skin, and heart'. did not produce either
1,25(OH)2D,3 or 24,25(OH)2D3 in vitro (Table 1).
Peak IV was produced by cells from calvaria and kidney.
Because the production of the metabolite was regulated by
1525(OH)2D3, it might represent a specific product of biological
significance. Peak IV has previously been shown to be produced
by chicken, quail, and rat kidney cells (10, 13, 14) and has been
identified in serum from rats (15) and quail (unpublished data).
In contrast, metabolite V was produced by all cell types tested
and did not appear to be regulated by 1,25(0H)2D3, suggesting
that it may represent a nonspecific degradative product.
Effect of Incubation Time on Synthesis of I,25OH~aD
and 24,A5E1H&I)3 by Culiued Cahvranal Cells. 25(OH)[3H]D3
was hydroxylated by calvarial cells to 1,25(OH)2[3H]D3 at a
linear rate for incubations-of up to 4 hr (Fig. 5). Similarly,
24525(OH)2[3H]D3 was produced in a linear manner. During










* Cells were isolated from tissue pooled from two or three individ-
uals.
t Two 60-mm dishes of cells were pooled for each determination.
























FIG. 3. HPLC of the putative 24,25(OH)2[3HJD3 region after
LH-20 column chromatography. Cultured calvarial cells were incu-
bated with 25(0H)[3H]D3 for 2 hr. The vitamin D metabolites were
extracted and chromatographed on Sephadex LH-20 (Fig. 2). The
peak fractions in the appropriate region were then chromatographed.
Elution profiles for synthetic 24,25(OH)2D3 (-) as followed by UV
absorption at 254 nm and for the putative 24,25(OH)2[3H]D3 (---)
as followed by liquid scintillation counting are shown for two chro-
matographic systems: (A) Straight-phase HPLC using a hexane/
isopropanol (90:10) solvent system at a flow rate of 1 ml/min and (B)
reverse-phase HPLC using a mobile phase of methanol/water (gra-
dient of 75:25 to 95:5 over 30 min) at a flow rate of 1 ml/min.
our standard 2-hr incubation, 12-16% of the initial substrate
was metabolized to more-polar products, of which approxi-
mately 15% was 1,25(OH)2D3 and approximately 60% was
24,25(OH)2D3.
Regulation of 25(OH)D3:1- and 24-Hydroxylases in Cul-
tured Calvarial Cells. Preincubation with 1,25(OH)2D3 altered
the subsequent metabolism of 25(OH)[3H]D3 by cultured cal-
varial cells The specific activity of the 25(OH)D3:1-hydroxylase
was reduced to 39% of the control value after cells from the
same preparation had been preincubated with 10 nM
1,25(OH)2D3 for 8 hr (Table 2) and assayed at the same time.
In contrast, the specific activity of the 24-hydroxylase was in-





Treatment n ylase ylase bolite IV
None 3* 0.81 0.09t 3.14 ±0.19 0.78 + 0.10
Preincubation 3 0.29 i 0.02? 7.69 i 0.13? 1.82 + 0.02?
with 10 nM
1,25(OH)2D3
* Two 60-mm dishes of cells were pooled for each determination.
t Mean + SD.
I Differs from untreated, P < 0.01.
B
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FIG. 4. HPLC of the putative 1,25(OH)2[3H]D3 region after
Sephadex LH-20 column chromatography. Culture conditions were
as for Fig. 3. Elution profiles for synthetic 1,25(OH)2D3 (-) as fol-
lowed by UV absorption at 254 nm and for the putative
1,25(OH)2[3H]D3 (---) as followed by liquid scintillation counting
are shown for three chromatographic systems. (A) Straight-phase
HPLC on a Zorbax-Sil column (4.6 mm X 25 cm) using a hexane/
isopropanol (90:10) solvent system at a flow rate of 1 ml/min. (B)
Straight-phase HPLC on the same column as in A using a hexane/
isopropanol (87:13) solvent system at a flow rate of 1 ml/min; the
1,25(OH)2D3 region had been recycled by rechromatographing it
through the column four times. (C) Reverse-phase HPLC of the
putative 1,25(OH)2[3HJD3 from the hexane/isopropanol (87:13) HPLC
using a mobile phase of methanol/water (gradient of 75:25 to 95:5 over
30 min) at a flow rate of 1 ml/min.
creased by 245%, and the rate of production of metabolite IV
was increased by 233%. Finally, the amount of metabolite V
produced was not altered by 1,25(OH)2D3.
Metabolites of 25(OH13HI)3 Produced by Cells Isolated
from Selected Chicken Embryo Organs. The tissue specificity
of the 25(OH)D3:1- and 24-hydroxylases in 16-day embryos was
determined by assaying enzyme activity in cells isolated from
selected organs. The cells isolated from calvaria and kidney
hydroxylated 25(OH)D3 to 1,25(0H)2D3 and 24,25(OH)2D3,
whereas the cells isolated from liver, skin, and heart did not
appear to have this capacity (Table 1).
The specific activity of the 25(OH)D3:24-hydroxylase in
calvarial cells was 3.8 (fmol/min)/106 cells, a value considerably
larger than that for kidney cells [(0.2 fmol/min)/106 cells]. In
contrast, the specific activity of the 25(OH)D3:1-hydroxylase
in kidney cells was larger than that in calvarial cells [7.2 com-
pared with 1.2 (fmol/min)/106 cells]. These results suggest that
the distribution of the 25(OH)Dl:1- and 24-hydroxylases within
calvarial cells differs from that in kidney cells grown under
identical conditions. However, the relative abundance of cells
in either calvaria or kidney involved in metabolizing 25(OH)D3
is not known. Also, it is not known whether our cell culture




FIG. 5. Effect of incubation time on metabolism of 25(OH)[3HJD3
by chicken embryo calvarial cells. 25(OH)[3HJD3 (7 nM) was incu-
bated with confluent cultures of cells, and the products were separated
by chromatography.
be particularly important if the 1- and 24-hydroxylases are lo-
cated in different cell populations. Based on these consider-
ations, it will be difficult to evaluate the significance of dif-
ferences in vitamin D metabolism in cells of renal and calvarial
origin until specific populations of cells containing the
25(OH)D3:1- and 24-hydroxylases are isolated.
DISCUSSION
The results of this study demonstrate that cultured calvarial cells
metabolize 25(OH)D3 to more-polar products, including
1,25(OH)2D3 and 24,25(OH)2D3. The identity of these two
metabolites is reasonably secure, based on the results of several
complementary techniques: Sephadex LH-20 column chro-
matography, recycling on straight-phase HPLC, and
straight-phase followed by reversed-phase HPLC.
A fundamental question raised by this study is whether the
apparent participation of the skeleton in metabolism of vitamin
D has a significant role in regulation of mineral homeostasis.
Several lines of evidence suggest that this is the case: (i)
25(OH)D3, the principal circulating metabolite of vitamin D,
is hydroxylated by calvarial cells to products that are of biologic
importance [i.e., 1,25(OH)2D3 and 24,25(OH)2D3]; (ii) the
distribution of 25(OH)D3:1- and 24-hydroxylases in chicken
embryos is organ-specific (i.e., the two enzymes are located in
cells from kidney and calvaria but not in cells from liver, skin
and heart); (ii) the in vitro metabolism of 25(OH)D3 by cal-
varial cells is altered dramatically by 1,25(OH)D3, a metabolite
that has previously been shown to be a potent regulator of vi-
tamin D metabolism in vivo (16) as well as by kidney cells in
culture (10); and (iv) the specific activities of 25(OH)D3:1- and
24-hydroxylases in cultured calvarial cells are of the same order
of magnitude as those in kidney cells.
Localization of 25(OH)D3:1-hydroxylase in calvarial cells
appears to be discrepant with the fact that 1,25(oH)2D3 has not
been reported in plasma from either nephrect6mized male rats
or anephric humans (17, 18). There are, however, several pos-
sible explanations for this apparent discrepancy. These include
the following: (i) calvarial cells produce 1,25(OH)2D3 but do
not release it into circulation; (ii) calvarial cells produce
1,25(OH)2D3 and release it, but in quantities that are nonde-
tectable by conventional assays; and (iii) synthesis of
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both). Regardless of which of these possibilities is correct, there
is precedence for extrarenal 25(OH)D3:1-hydroxylase activity
in mammals and birds: 1,25(OH)2D3 is synthesized by rat pla-
centa (5-7) and by chicken chorioallantoic membrane (19).
There are other in vivo observations that are consistent with
the hypothesis that the skeleton is a site of 1,25(OH)2D3 pro-
duction. 1,25(OH)2D3 and PTH are important physiological
determinants of osteoclast number (reviewed in ref. 20). In
vitamin D-deficient rats [in which serum 25(OH)D3 and
1,25(OH)2D3 are markedly reduced], 7-fold increases in PTH
are not associated with an increase in osteoclast number (20-22).
In sharp contrast, in anephric patients [in whom 25(OH)D3
levels are normal], PTH elevation no greater than that seen in
vitamin D-deficient rats is associated with a marked increase
in osteoclast number (23-25). Apart from reservations con-
cerning species differences, these findings suggest that adequate
25(OH)D3 is required for PTH-mediated increases in osteoclast
number, possibly because of further metabolism to
1,25(OH)2D3 by the skeleton.
Production of active vitamin D metabolites in vitamin D
target organs may provide a means of local regulation of the
response to vitamin D. This duplication of synthetic activity
may provide a more versatile control of calcium and phosphorus
metabolism. For example, under certain physiological condi-
tions there may be some advantage for a differential response
by gut and bone, as mediated by different amounts or types of
locally determined vitamin D metabolites. Moreover, it would
not be surprising that other target organs, such as gut, partici-
pate in the metabolism of 25(OH)D3. In keeping with this
concept, the intestine has been shown to produce 24,25(OH)2D3
(26).
In summary, we have identified 25(OH)D3:1-hydroxylase
activity in cultured chicken calvarial cells. This finding con-
stitutes evidence that production of 1,25(OH)2D3 is more
widespread than previously believed. Furthermore, the local
production of active metabolites of vitamin D by target organs
such as bone raises interesting questions as to the role of these
tissues in mediating vitamin D action. The answers to these
questions may provide a new dimension to regulation of min-
eral metabolism by vitamin D.
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